How SARS-CoV-2 evades the immune system

Researchers in Japan and the United States have found SARS-CoV-2 can knock out an important molecular pathway linked to an immune complex called MHC class I. The finding should help scientists better understand how COVID-19 infection takes hold.

New study forecasts how SARS-CoV-2 variants could evade vaccines — Harvard Gazette

Why Viruses Like SARS-CoV-2 Can Reinfect Us, Evade Immune Response - Harvard Catalyst

Innate immune sensing of coronavirus and viral evasion strategies

Shape-shifting Protein Helps SARS-CoV-2 Evade Human Immune Defenses - Biosciences Area

A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress Response to Reactive Oxygen Species

SARS-CoV-2 evolution and implications for immunity Vanderbilt Institute for Infection, Immunology and Inflammation

Alpha Coronavirus Variant Evolved to Evade Immune System

SARS-CoV-2 learned the 'Alpha'bet of immune evasion

Immune response to SARS-CoV-2 in severe disease and long COVID-19 - ScienceDirect

Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines

Full article: ORF6, a repressor of the MHC class I pathway: new molecular target for SARS-CoV-2 drug discovery?